Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Leukemia, Myeloid, Acute × Topotecan × Clear all

Phase

Status

Completed 13 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Small Cell Lung Carcinoma 8 Ovarian Neoplasms 5 Retinoblastoma 3 Neuroblastoma 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Sarcoma, Ewing 1 SCLC 1 Recurrence 1 Pleuropulmonary blastoma 1 Pediatric Brain Tumor 1 Neoplasms 1 Medulloblastoma 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Glioma 1 Ganglioneuroblastoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

venetoclax 115 Azacitidine 90 Cytarabine 62 fludarabine 41 Specimen Handling 33 Cyclophosphamide 33 Biopsy 24 Decitabine 23 Daunorubicin 23 Idarubicin 21 Granulocyte Colony-Stimulating Factor 18 fludarabine phosphate 17 Injections 17 Whole-Body Irradiation 15 gilteritinib 14 Melphalan 14 Busulfan 13 ivosidenib 11 Stem Cell Transplantation 11 Mycophenolic Acid 11 Gemtuzumab 11 Cladribine 11 CPX-351 11 enasidenib 9 decitabine and cedazuridine drug combination 9 revumenib 8 Tacrolimus 8 Magnetic Resonance Spectroscopy 8 Filgrastim 8 tagraxofusp 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05101551 2025-05-29

PARPAML

Stanford University

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡